Talking to Your Doctor About CLL

Before starting treatment, you may have questions. It’s important to get the answers. Remember, your doctor and nurse are the best sources of information. Make a list of questions to ask your healthcare team.

It’s a good idea to take along a family member or friend to help you keep track of the answers. The questions below are a good starting point for a discussion about your CLL.

Your CLL Questions List

Download or print your CLL questions list to take with you.

Your CLL questions list

Do I need treatment?
How do you determine when treatment is needed?
What are my treatment options?
What will my treatment schedule be?
What are the risks and side effects of my treatment?
Is there more I can do to make the most of my treatment?
Where can I find information about support to help me pay for my therapy?
Where can I get more information about some treatment options for CLL?

This information does not take the place of talking with your doctor. Discuss with your doctor any questions you have about your medical condition or your treatment.

Next Section About RITUXAN

Indications

RITUXAN® (Rituximab) is indicated in combination with fludarabine and cyclophosphamide (FC chemotherapy) for the treatment of patients with:

Previously untreated CD20-positive CLL
Previously treated CD20-positive CLL

People with serious infections should not receive RITUXAN.

Safety Information

RITUXAN can cause serious side effects that can lead to death, including: infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection).
RITUXAN has also been associated with serious and life-threatening side effects, including: the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death.
The most common side effects of RITUXAN seen in clinical trials of patients with CLL were infusion reactions and low white blood cells, which can increase the risk of infections. Before starting treatment with RITUXAN it is important for you to talk to your doctor about your medical history.
Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor.

Please see full Prescribing Information, including Medication Guide, in PDF format.